Literature DB >> 26937145

Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients.

Chun Gao1, Long Fang1, Jing-Tao Li1, Hong-Chuan Zhao1.   

Abstract

AIM: To determine the significance of increased serum direct bilirubin level for lymph node metastasis (LNM) in Chinese rectal cancer patients, after those with known hepatobiliary and pancreatic diseases were excluded.
METHODS: A cohort of 469 patients, who were treated at the China-Japan Friendship Hospital, Ministry of Health (Beijing, China), in the period from January 2003 to June 2011, and with a pathological diagnosis of rectal adenocarcinoma, were recruited. They included 231 patients with LNM (49.3%) and 238 patients without LNM. Follow-up for these patients was taken through to December 31, 2012.
RESULTS: The baseline serum direct bilirubin concentration was (median/inter-quartile range) 2.30/1.60-3.42 μmol/L. Univariate analysis showed that compared with patients without LNM, the patients with LNM had an increased level of direct bilirubin (2.50/1.70-3.42 vs 2.10/1.40-3.42, P = 0.025). Multivariate analysis showed that direct bilirubin was independently associated with LNM (OR = 1.602; 95%CI: 1.098-2.338, P = 0.015). Moreover, we found that: (1) serum direct bilirubin differs between male and female patients; a higher concentration was associated with poor tumor classification; (2) as the baseline serum direct bilirubin concentration increased, the percentage of patients with LNM increased; and (3) serum direct bilirubin was associated with the prognosis of rectal cancer patients and higher values indicated poor prognosis.
CONCLUSION: Higher serum direct bilirubin concentration was associated with the increased risk of LNM and poor prognosis in our rectal cancers.

Entities:  

Keywords:  Direct bilirubin; Lymph node metastasis; Prognosis; Rectal cancer; Risk

Mesh:

Substances:

Year:  2016        PMID: 26937145      PMCID: PMC4768203          DOI: 10.3748/wjg.v22.i8.2576

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Serum bilirubin and 10-year mortality risk in a Belgian population.

Authors:  E H Temme; J Zhang; E G Schouten; H Kesteloot
Journal:  Cancer Causes Control       Date:  2001-12       Impact factor: 2.506

2.  Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer.

Authors:  W F Ko; K J Helzlsouer; G W Comstock
Journal:  J Natl Cancer Inst       Date:  1994-12-21       Impact factor: 13.506

3.  Bilirubin is an antioxidant of possible physiological importance.

Authors:  R Stocker; Y Yamamoto; A F McDonagh; A N Glazer; B N Ames
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

4.  UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity.

Authors:  L Iyer; S Das; L Janisch; M Wen; J Ramírez; T Karrison; G F Fleming; E E Vokes; R L Schilsky; M J Ratain
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

5.  Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports.

Authors:  E Wasserman; A Myara; F Lokiec; F Goldwasser; F Trivin; M Mahjoubi; J L Misset; E Cvitkovic
Journal:  Ann Oncol       Date:  1997-10       Impact factor: 32.976

6.  Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancer.

Authors:  Jeffrey A Meyerhardt; Ambrose Kwok; Mark J Ratain; J Patrick McGovren; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

7.  Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization.

Authors:  Pavitra Keshavan; Sandy J Schwemberger; Darcey L H Smith; George F Babcock; Stephen D Zucker
Journal:  Int J Cancer       Date:  2004-11-10       Impact factor: 7.396

8.  Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer.

Authors:  Stephen D Zucker; Paul S Horn; Kenneth E Sherman
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

9.  The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.

Authors:  Young-Wan Kim; Nam-Kyu Kim; Byung-Soh Min; Kang-Young Lee; Seung-Kook Sohn; Chang-Hwan Cho
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

10.  Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups.

Authors:  G Freyer; P Rougier; R Bugat; J P Droz; M Marty; H Bleiberg; D Mignard; L Awad; P Herait; S Culine; V Trillet-Lenoir
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

View more
  10 in total

1.  The prognostic impact of serum bilirubin in stage IV colorectal cancer patients.

Authors:  Lin Yang; Lu-Yao Ge; Ting Yu; Yan Liang; Ying Yin; Hong Chen
Journal:  J Clin Lab Anal       Date:  2017-11-23       Impact factor: 2.352

Review 2.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

3.  A nomogram based on serum bilirubin and albumin levels predicts survival in gastric cancer patients.

Authors:  Huiling Sun; Bangshun He; Zhenlin Nie; Yuqin Pan; Kang Lin; Hongxin Peng; Tao Xu; Xiaoxiang Chen; Xiuxiu Hu; Zijuan Wu; Di Wu; Shukui Wang
Journal:  Oncotarget       Date:  2017-06-20

4.  Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma.

Authors:  Chenyue Zhang; Haiyong Wang; Zhouyu Ning; Litao Xu; Liping Zhuang; Peng Wang; Zhiqiang Meng
Journal:  Onco Targets Ther       Date:  2017-03-06       Impact factor: 4.147

5.  A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients.

Authors:  Yinghao Cao; Shenghe Deng; Lizhao Yan; Junnan Gu; Jia Yang; Ming Yang; Li Liu; Kailin Cai
Journal:  BMC Cancer       Date:  2021-01-21       Impact factor: 4.430

6.  A Novel Systematic Oxidative Stress Score Predicts the Prognosis of Patients with Operable Breast Cancer.

Authors:  Kaiming Zhang; Liqin Ping; Tian Du; Yan Wang; Ya Sun; Gehao Liang; Xi Wang; Xiaoming Xie; Weidong Wei; Xiangsheng Xiao; Jun Tang
Journal:  Oxid Med Cell Longev       Date:  2021-10-07       Impact factor: 6.543

7.  Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study.

Authors:  Tilman Kühn; Disorn Sookthai; Mirja E Graf; Ruth Schübel; Heinz Freisling; Theron Johnson; Verena Katzke; Rudolf Kaaks
Journal:  Br J Cancer       Date:  2017-09-12       Impact factor: 7.640

8.  Nomograms incorporated serum direct bilirubin level for predicting prognosis in stages II and III colorectal cancer after radical resection.

Authors:  Qunfeng Zhang; Xiaowei Ma; Qunhuan Xu; Juanxiu Qin; Yanhua Wang; Qian Liu; Hua Wang; Min Li
Journal:  Oncotarget       Date:  2016-08-19

9.  A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma.

Authors:  Lei Chen; Bin-Bin Cai; Chao-Jun Zhou; Xiang-Qing Hou; Si-Pin Hu; Guan Fang; Wen-Chao Chen; Lin-Hui Li; Wen-Jun Yang
Journal:  Cancer Manag Res       Date:  2019-01-14       Impact factor: 3.989

10.  Is serum bilirubin level a predictor factor in parotid gland carcinoma?

Authors:  Suphi Bulğurcu; Mehmet İdil; İbrahim Çukurova
Journal:  Braz J Otorhinolaryngol       Date:  2019-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.